InvestorsHub Logo
Post# of 252313
Next 10
Followers 833
Posts 119895
Boards Moderated 17
Alias Born 09/05/2002

Re: biomaven0 post# 190901

Wednesday, 05/06/2015 2:14:17 PM

Wednesday, May 06, 2015 2:14:17 PM

Post# of 252313
ALXN-GEVA premium is the third-largest ever (largest for a biotech) for a US deal valued at $5B or more:

http://blogs.wsj.com/moneybeat/2015/05/06/alexion-pharmaceuticals-premium-for-synageva-is-fourth-highest-on-record/

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.